Finance

Lists
SSKN:OTCMKTS
STRATA Skin Sciences Inc
0,00020 $
0,00%
(0,00) 1D
9 հոկ, 10:31:45 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SSKN...
Mkt. cap
1,18 հզր
Avg. vol.
2,18 հզր
Volume
3,00
52-wk high
2,65 $
52-wk low
0,00 $
EPS
-1,35 $
Beta
0,06
Shares outstanding
5,89 մլն
No. of employees
114
Mkt. cap
1,18 հզր
Avg. vol.
2,18 հզր
Volume
3,00
52-wk high
2,65 $
52-wk low
0,00 $
EPS
-1,35 $
Beta
0,06
Shares outstanding
5,89 մլն
No. of employees
114
News stories
From web sources and news partners
Profile
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union. In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
About STRATA Skin Sciences Inc
CEO-
Employees114
Founded01 հնվ, 1989 թ.
HeadquartersHorsham Township, Փենսիլվանիա, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
6,81 մլն
7,66 մլն
6,93 մլն
9,29 մլն
Cost of goods sold
3,16 մլն
3,36 մլն
2,74 մլն
3,68 մլն
Cost of revenue
3,16 մլն
3,36 մլն
2,74 մլն
3,68 մլն
Research and development expenses
96,00 հզր
86,00 հզր
172,00 հզր
67,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,57 մլն
6,44 մլն
5,87 մլն
5,51 մլն
Operating expense
5,66 մլն
6,53 մլն
6,04 մլն
5,58 մլն
Total operating expenses
8,83 մլն
9,89 մլն
8,79 մլն
9,26 մլն
Operating income
-2,02 մլն
-2,22 մլն
-1,86 մլն
37,00 հզր
Other non operating income
-
-
-
-
EBT including unusual items
-2,43 մլն
-2,49 մլն
-1,62 մլն
70,00 հզր
EBT excluding unusual items
-2,43 մլն
-2,49 մլն
-2,31 մլն
-381,00 հզր
Income tax expense
-
-
-
12,00 հզր
Effective tax rate
-
-
-
17,14%
Other operating expenses
-
-
-
-
Net income
-2,43 մլն
-2,49 մլն
-1,62 մլն
58,00 հզր
Net profit margin
-35,70%
-32,48%
-23,41%
0,62%
Earnings per share
-0,58
-0,60
-0,36
-
Interest and investment income
69,00 հզր
226,00 հզր
49,00 հզր
66,00 հզր
Interest expense
-486,00 հզր
-491,00 հզր
-498,00 հզր
-484,00 հզր
Net interest expenses
-417,00 հզր
-265,00 հզր
-449,00 հզր
-418,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-795,00 հզր
-1,01 մլն
-993,00 հզր
858,00 հզր
Gain or loss from assets sale
34,00 հզր
29,00 հզր
20,00 հզր
9,00 հզր
AI content may include mistakes. Learn more
Google Apps